Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,150 | -7,920 | -6,527 | -1,253 | -494 |
| Depreciation Amortization | 18 | 23 | 9 | 4 | 1 |
| Accounts payable and accrued liabilities | -104 | 133 | 271 | 181 | 16 |
| Other Working Capital | -302 | 575 | 1,106 | 376 | 42 |
| Other Operating Activity | 169 | 3,299 | 3,378 | 27 | 178 |
| Operating Cash Flow | $-2,369 | $-3,890 | $-1,763 | $-665 | $-257 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -210 | -51 | -39 | -7 |
| Investing Cash Flow | $N/A | $-210 | $-51 | $-39 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,299 | 2,299 | 2,299 | 300 |
| Common Stock Issued | 6 | 42,469 | 43,162 | N/A | N/A |
| Other Financing Activity | 0 | 7,000 | 7,000 | 0 | 0 |
| Financing Cash Flow | $6 | $51,768 | $52,461 | $2,299 | $300 |
| Beginning Cash Position | 49,591 | 1,923 | 1,923 | 1,923 | 1,923 |
| End Cash Position | 47,228 | 49,591 | 52,570 | 3,518 | 1,959 |
| Net Cash Flow | $-2,363 | $47,668 | $50,647 | $1,595 | $36 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,369 | -3,890 | -1,763 | -665 | -257 |
| Capital Expenditure | N/A | -210 | -51 | -39 | -7 |
| Free Cash Flow | -2,369 | -4,100 | -1,814 | -704 | -264 |